Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sacubitril/Valsartan in Chagas Cardiomyopathy
NCT04853758Phase 3Recruiting
- Sponsor
- Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo
- Start
- May 2021
- Primary completion
- Dec 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of sacubitril + valsartan in Chagas cardiomyopathy (CCC), sponsored by Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo. Started May 2021; status: recruiting.
02
Drugs
sacubitril + valsartan
03
Conditions
Chagas cardiomyopathy (CCC)
Beyond the preview
Go deeper on NCT04853758.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04853758.